Drug Repurposing (DR) is a is a Diamond Open Access journal hosted by our partner ScienceOpen, and dedicated to accelerating drug repurposing through high-impact research in Network and Systems Medicine, bioinformatics, (pre)clinical validation, patenting, business development, regulatory science and health-technology assessment – all for rapid and precise patient benefit.
The journal aims to provide an interdisciplinary and cross-sectional overview of the various fields of research and applied sciences that work together to make successful drug repurposing projects a reality. High-throughput and high-content screening, in silico docking studies, pathway-based molecular pharmacology, bioinformatics, mining of peer-reviewed literature, patent documents, and side effect records, and design of drug repurposing trials are all part of this.